Loading...
The Aminobisphosphonate Risedronate Preserves Localized Mineral and Material Properties of Bone in the Presence of Glucocorticoids
OBJECTIVE. Glucocorticoids (GCs) alter bone strength such that patients receiving these medications have a high rate of fragility-related fractures. The purpose of this study was to assess whether concurrent treatment with GCs (prednisolone) and risedronate (an aminobisphosphonate) would prevent the...
Na minha lista:
| Udgivet i: | Arthritis Rheum |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913894/ https://ncbi.nlm.nih.gov/pubmed/17968931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.22976 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|